Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis

Hepatology- United States

doi 10.1002/hep.29025

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Antifibrotic Effect of Pirfenidone in a Mouse Model of Human Nonalcoholic Steatohepatitis

Scientific Reports
Multidisciplinary
2017English

MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis Without Reducing Inflammation in a Mouse Model of Steatohepatitis

PLoS ONE
Multidisciplinary
2015English

Comprehensive Circular RNA Expression Profiles in a Mouse Model of Nonalcoholic Steatohepatitis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Targeting Mitochondrial Pyruvate Carrier (MPC) in NASH: Growing Evidence and Future Challenges

Hepatology
MedicineHepatology
2018English

Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2013English

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis

Frontiers in Medicine
Medicine
2020English

Nonalcoholic Steatohepatitis

English

Pioglitazone for Advanced Fibrosis in Nonalcoholic Steatohepatitis: New Evidence, New Challenges

Hepatology
MedicineHepatology
2017English

Farnesoid X Receptor Agonist INT-767 Attenuates Liver Steatosis and Inflammation in Rat Model of Nonalcoholic Steatohepatitis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy